We have proposed that “MR-associated hypertension and its organ damage” exists in patients with diabetes, obesity, and CKD, in which MR signaling is enhanced regardless of an increase in plasma aldosterone levels [9]. This evidence concerns the gene NR3C2 and obesity due to melanocortin 4 receptor deficiency.